Key takeaways:
- 50.4% of adults with IBS reported ARFID symptoms in a 2026 study.¹
- One open question, "Tell me about your relationship with food," can start ARFID screening in any visit.²
- Adults who screen positive need professional care from a dietitian and a GI psychology specialist.²
- In the US, 46% of adults live more than 25 miles from a listed in-person GI psychology specialist.³
Screening for avoidant/restrictive food intake disorder (ARFID) is an important consideration in IBS care, with 50.4% of adults with IBS reporting symptoms in a 2026 Gastroenterology study.¹ For patients who screen positive, a referral to a specialist in GI psychology or eating disorders can help guide further assessment.
Screening matters because ARFID is easy to miss. A patient who has cut out a whole food group like dairy, or specific foods like onion or wheat, after bad flares can sound like they're managing well. But when the list keeps growing, weight drops, or meals start to cause dread, it may be ARFID and not careful eating.
And it's not just something for specialists to consider. Gastroenterologists, advanced practice providers (APPs), dietitians, primary care clinicians, and other clinicians who support people with IBS all have opportunities to identify patients who may need further assessment.
Here's what the new data shows, how to screen in a routine visit, and who to bring in when a patient screens positive.
What the 2026 ARFID study found in adults with IBS and gut-brain disorders
ARFID symptoms were common across gut-brain disorders and rose with the number of GI regions affected, from 27.7% with one region to 61.4% with four.¹ The survey of 4,002 adults in the UK and US found 50.4% of those meeting IBS criteria screened positive, and 56.2% of those with functional dyspepsia.¹
A positive screen isn't a diagnosis, but the burden that came with it was clear:²
| Measure | Gut-brain disorder with positive ARFID screen | Gut-brain disorder alone |
|---|---|---|
| Anxiety | 51.0% | 33.0% |
| Depression | 49.2% | 32.0% |
| Underweight | 7.9% | 1.5% |
The other surprise was what drove the restriction. Low interest in eating (21.5%) and sensory-based avoidance (18.1%) were both more common than fear of GI symptoms (9.9%).¹ So the patient who's never hungry, or who sticks to a handful of textures, deserves the same attention as the one who's afraid to eat.
How to tell ARFID from reasonable food restriction in IBS
ARFID becomes a concern when restriction starts costing the patient something: weight, nutrition, reliance on supplements, or the ability to eat at work or with others.⁴ Avoiding a food that reliably triggers symptoms, with none of those costs, can be sensible IBS management.
Fear-driven restriction is the version most often accepted as reasonable:
"Disordered eating can come from body image concerns, fear of GI symptoms, or both. And while fear-driven restriction is common, we don't want to normalize that. Instead, we want to give patients tools and support to address it."
– Brittany Rogers, Registered Dietitian, Founder of Roman Well
Applying this in practice
Ask what actually happens when the patient eats an avoided food. A clear, repeatable reaction suggests intolerance. A vague or expected reaction ("I just know it'll set me off") suggests fear. Then look at the cost: weight trend, nutrient gaps, supplement use, and social eating.
How to screen for ARFID in a routine IBS visit
Screening for ARFID can start with one open question, "Tell me about your relationship with food," or a 24-hour dietary recall.² If you want a structured tool, the Nine Item ARFID Screen (NIAS) takes a few minutes and separates picky eating, low appetite, and fear.⁵ ⁶
| NIAS subscale | What it picks up | Positive screen |
|---|---|---|
| Picky eating | A narrow range of accepted foods, often driven by taste, texture, or smell | 10 or more |
| Appetite | Low interest in eating, feeling full quickly, forgetting to eat | 9 or more |
| Fear | Avoiding food because of fear of pain, nausea, vomiting, or other symptoms | 10 or more |
Each subscale has three items, and a positive score on any one is enough to warrant follow-up. The NIAS developers suggest pairing it with a screen for shape- and weight-based eating disorders, such as the Eating Disorder Examination Questionnaire (EDE-Q).⁶
Read a positive NIAS with care in GI patients. Gut symptoms can push scores up on their own, so the tool can flag disease-driven restriction as ARFID.⁷ Treat a positive result as the start of a conversation, not a diagnosis.
Timing matters too. The American Gastroenterological Association (AGA) advises checking for disordered eating before starting any restrictive diet.⁸ For patients who screen positive, a dietitian who specializes in gut health can judge whether a time-limited diet is still appropriate.
Applying this in practice
Ask the open question at intake, before any elimination diet, and whenever a patient reports new food avoidance or unplanned weight loss. Look more closely at patients with symptoms in several GI regions, given how sharply ARFID symptoms rose with each one.¹
Who to bring in when an IBS patient screens positive for ARFID
A positive ARFID screen calls for multidisciplinary care, with a dietitian and a clinician trained in GI-focused psychological care working alongside the medical team.²
Gastroenterologist, APP, or primary care clinician: confirms the GI diagnosis, checks weight and nutrition, and coordinates referrals.
Dietitian with eating disorder experience: restores nutritional adequacy and plans gradual food reintroduction.
GI psychology specialist or eating disorder clinician: works on the fear and avoidance that keep restriction going.
If you're the dietitian on the case, you're often well placed to spot ARFID first, since a narrowing diet shows up in food records and recalls before it shows up in a GI visit. Nutrition rehabilitation and food reintroduction sit with you, but the fear and avoidance driving the restriction usually need a psychology referral alongside your care. If ARFID is outside your usual caseload, a dietitian with eating disorder training, such as a Certified Eating Disorders Registered Dietitian (CEDRD) in the US, can co-manage or take on the case.
The therapy with the most evidence in adults is cognitive-behavioral therapy for ARFID (CBT-AR). In its first adult study, 47% of patients no longer met ARFID criteria after treatment.⁹ When you refer, ask whether the clinician offers CBT-AR or exposure work with fear foods.
"We would also do some GI specific CBT and some acceptance and commitment therapy as well to address whatever gut directed symptom related anxiety he might be having. So exposure to fear foods, mindfulness of gut sensations…"
– Dr. Kelli Rugless, Licensed Health Psychologist, Certified Eating Disorder Specialist, Owner of Flourish Psychology
Why ARFID referrals stall: access to GI psychology care
Finding a GI psychology specialist is often the hardest part of an ARFID referral. In the US, 46% of adults live more than 25 miles from a listed in-person specialist, according to our GI psychology access map.³ That's around 120 million adults. Sixteen states have no listed in-person GI psychology specialist at all, and nationally there's roughly one for every 750,000 adults.³
For ARFID, the pool is smaller still. The ideal clinician understands both gut-brain disorders and eating disorders, and distance is only part of the picture. A listed specialist may have a long waitlist or may not be taking new patients.³ Psychological care is also rarely offered in the first place: 9 in 10 US adults with bowel gut-brain disorders had never been offered cognitive behavioral therapy, according to a 2026 survey.¹⁰
Check GI psychology access for US patients
For clinicians in the US, our GI psychology access map shows how far adults in every state and county live from a listed in-person GI psychology specialist.
Click the map below to search your patient’s state or county before you refer.
Where to find care for patients with ARFID in the US
Rome Foundation GastroPsych Directory: search for GI psychology specialists by location, including clinicians who offer telehealth.
National Alliance for Eating Disorders: Find Treatment: a free helpline and searchable database of eating disorder therapists, dietitians, and programs, including outpatient and telehealth options.
ANAD Eating Disorders Helpline: free emotional support and treatment referrals, plus free virtual peer support groups patients can join while they wait.
Academy of Nutrition and Dietetics: Find a Nutrition Expert: search for registered dietitians by specialty, including eating disorders.
In Australia: the Butterfly Foundation Helpline offers support and referrals, and Dietitians Australia lists dietitians by specialty.
In the UK: Beat’s helplines offer support and help patients find eating disorder services.
In New Zealand: the Eating Disorders Association of New Zealand (EDANZ) offers support and information on eating disorder services.
In Canada: the National Eating Disorder Information Centre (NEDIC) offers a helpline and can connect patients with eating disorder services.
When you contact a clinician or program, ask whether they treat adults with ARFID and offer CBT-AR or exposure-based care. While patients wait, keep the dietitian involved for regular weight and nutrition checks.
The gap doesn't change who these patients need. Self-guided tools aren't a substitute for professional care in ARFID, however long the wait.¹¹
For more on how GI conditions and eating disorders overlap, see integrative approaches to managing gastrointestinal conditions and eating disorders and the conditioned food restriction and sensitivity trap.
Where gut-brain therapy fits, and where it doesn't
Gut-brain therapy apps, including Nerva, aren't suitable for patients with active ARFID or another eating disorder. These patients need professional care from a dietitian, a GI psychology specialist, or an eating disorder team.¹¹ Further along in recovery, their treating team can decide whether self-guided gut-brain therapy has a place in their ongoing IBS care.
That leaves a large group in between: patients who screen negative for ARFID but still link their symptoms to food. Gut-brain therapy targets the gut sensitivity that can make eating feel risky, and food-triggered patients respond to it. In our Australian Gastroenterology Week 2026 analysis of 26,008 users, people who named food as their main IBS trigger improved as much as those who named stress (23.0% vs 23.4%).¹²
Nerva is one way to offer that therapy without a specialist wait. It's a digital program patients use on their phone, combining gut-directed hypnotherapy with CBT-informed education and breathing exercises, and it asks for no dietary changes.
In a randomized controlled trial of 244 adults with IBS, 81% of Nerva participants had a clinically meaningful improvement in IBS symptoms, compared with 63% on an active control.¹³
For patients who've screened negative for eating disorders, you can refer through the online referral form or simply recommend Nerva.
Frequently asked questions
What are the common gastrointestinal issues associated with ARFID?
Gut-brain disorders are common in people with ARFID: in an eating disorder clinic, 30% of patients with ARFID met criteria for one.¹⁴ They were most often linked with the fear-driven type of ARFID.¹⁴
Can IBS cause ARFID?
IBS may contribute to ARFID when repeated symptoms after eating lead patients to fear or avoid food, but the 2026 study can't show which came first.¹ Researchers are still working out whether GI symptoms drive eating disorder symptoms or result from them.¹⁴
Who treats ARFID in adults with IBS?
ARFID in adults with IBS is treated by a team, usually a dietitian and a GI psychology specialist or eating disorder clinician working alongside the medical team.² CBT-AR has the strongest early evidence in adults, though trials in people with both ARFID and IBS are still needed.² ⁹
Is a low FODMAP diet safe for patients at risk of ARFID?
A low FODMAP diet needs caution in patients at risk of disordered eating, and the AGA advises screening for it before any restrictive diet.⁸ A dietitian who specializes in gut health can judge whether a time-limited trial is appropriate.
How do you refer a patient to a digital gut-brain therapy program?
You can refer a patient to Nerva through the online referral form or by recommending the program in a consult. Screen for ARFID and other eating disorders first, as Nerva isn't suitable for patients who have them.
About this analysis: Mindset Health, which makes Nerva, produced the US GI psychology access map from the Rome Foundation's GastroPsych Directory and US academic medical center data in November 2026.
References
Flack R, Brownlow G, Burton-Murray H, Palsson O, Aziz I. The prevalence and burden of avoidant/restrictive food intake disorder symptoms in adults with disorders of gut-brain interaction: a population-based study. Gastroenterology. 2026;170(2):365-374. doi:10.1053/j.gastro.2025.07.043
Brunk D. When gut-brain disorders affect eating in adults. GI & Hepatology News. January 2026. https://news.gastro.org/issues/2026/january/when-gut-brain-disorders-affect-eating-in-adults/
Mindset Health. GI Psychology Access Map. November 2026. https://www.nervahealth.com/clinician-resources/gi-psychology-access
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text revision. American Psychiatric Association Publishing; 2022.
Zickgraf HF, Ellis JM. Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): a measure of three restrictive eating patterns. Appetite. 2018;123:32-42.
Burton Murray H, Dreier MJ, Zickgraf HF, et al. Validation of the nine item ARFID screen (NIAS) subscales for distinguishing ARFID presentations and screening for ARFID. Int J Eat Disord. 2021;54(10):1782-1792. doi:10.1002/eat.23520
Osterweil N. ARFID or reasonable food restriction? The jury is out. MDedge. February 3, 2022. https://www.mdedge.com/content/arfid-or-reasonable-food-restriction-jury-out/page/0/1
Chey WD, Hashash JG, Manning L, Chang L. AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review. Gastroenterology. 2022;162(6):1737-1745.e5. doi:10.1053/j.gastro.2021.12.248
Thomas JJ, Becker KR, Breithaupt L, et al. Cognitive-behavioral therapy for adults with avoidant/restrictive food intake disorder. J Behav Cogn Ther. 2021;31(1):47-55. doi:10.1016/j.jbct.2020.10.004
Izquierdo Veraza D, Waseem MR, Venezia J, et al. Perceived utility of cognitive behavioral therapy in people with bowel disorders of gut–brain interaction. Neurogastroenterol Motil. 2026;38(3):e70283. doi:10.1111/nmo.70283
Penumalee LS, Kia L. Bridging the behavioral health gap: disorders of gut-brain interaction. GI & Hepatology News. August 2026. https://news.gastro.org/issues/2026/august-2026/bridging-the-behavioral-health-gap-in-disorders-of-gutbrain-interaction/
Dabash O, Hall C, Peters SL, Raik-Allen S. No difference in adherence or clinical response to a digital brain-gut behavioural therapy program among 26,008 users reporting food-related or stress-related primary symptom triggers. Abstract presented at: Australian Gastroenterology Week 2026; August 28–31, 2026; Perth, Australia.
Anderson EJ, Peters SL, Gibson PR, Halmos EP. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025;120(2):440-448. doi:10.14309/ajg.0000000000002921
Murray HB, Kuo B, Eddy KT, et al. Disorders of gut-brain interaction common among outpatients with eating disorders including avoidant/restrictive food intake disorder. Int J Eat Disord. 2021;54(6):952-958. doi:10.1002/eat.23414
.webp&w=3840&q=75)





